ライフサイエンスコーパス: knee arthroplasty

1 ing patellar component loosening after total knee arthroplasty.

2 in Total Hip Arthroplasty, and 18% in Total Knee Arthroplasty.

3 Elective total hip or knee arthroplasty.

4 mentia, admitted for primary elective hip or knee arthroplasty.

5 ol of patients eligible for outpatient total knee arthroplasty.

6 leading cause of mortality following hip and knee arthroplasty.

7 influencing pain and functional outcomes of knee arthroplasty.

8 ho were otherwise considered for unicondylar knee arthroplasty.

9 lications remain an important issue in total knee arthroplasty.

10 ially limb-threatening complication of total knee arthroplasty.

11 predicting adverse outcomes following total knee arthroplasty.

12 preventing symptomatic VTE following hip or knee arthroplasty.

13 n and function outcomes up to one year after knee arthroplasty.

14 ulation to ensure proper alignments in total knee arthroplasty.

15 infection (PJI) in aseptic revision hip and knee arthroplasty.

16 ogical treatments to reduce pain after total knee arthroplasty.

17 covery among patients after undergoing total knee arthroplasty.

18 or postoperative pain management after total knee arthroplasty.

19 from OA-affected joints at the time of total knee arthroplasty.

20 heparin for thromboprophylaxis after hip or knee arthroplasty.

21 e of enoxaparin in patients undergoing total knee arthroplasty.

22 o diagnosis of invasive SSI following hip vs knee arthroplasty.

23 the association between statin exposure and knee arthroplasty.

24 ented with late infection of his right total knee arthroplasty.

25 tilage was obtained from patients undergoing knee arthroplasty.

26 al of the trend of increasing rates of total knee arthroplasty.

27 thromboembolism in patients undergoing total knee arthroplasty.

28 rability in patients undergoing total hip or knee arthroplasty.

29 atients in the treatment group had undergone knee arthroplasty.

30 nd were associated with an increase in total knee arthroplasties.

31 ere identified; 401 (61%) occurred following knee arthroplasties.

32 y (-0.8%; 95% CI, -1.0% to -0.5%; P < .001), knee arthroplasty (-0.4%; 95% CI, -0.7% to -0.1%; P = .0

33 sion [4.3%; 95% CI, 3.4%-5.2%; P < .001] and knee arthroplasty [1.6%; 95% CI, 1.0%-2.3%; P < .001]) a

34 d diabetic man with a history of right total knee arthroplasty 11 years prior who had suffered multip

35 roplasty (70% female, 84% Chinese, 92% total knee arthroplasty), 1102 and 1089 provided data at 6- an

36 tention-to-treat population (2233 undergoing knee arthroplasty, 1850 undergoing hip arthroplasty, and

37 n males, 20.8 per 100 000 in females), total knee arthroplasty (19.9 per 100 000 persons in males, 12

38 sty (-$328; 95% CI, -$634 to -$21; P = .04), knee arthroplasty (-$415; 95% CI, -$643 to -$187; P < .0

39 r of procedures ranged between 729 855 total knee arthroplasties (47.21%) and 4558 esophagectomies (0

40 yme activity in patients undergoing elective knee arthroplasty (a standard reproducible surgical inju

41 8 through 2000 to determine the incidence of knee arthroplasty according to Hospital Referral Region,

42 ies in patients (aged >=50 years) undergoing knee arthroplasty across 15 centres in seven countries a

43 ained significantly shorter for hip than for knee arthroplasties after adjusting for age, pathogen vi

44 all, there were 679 hip arthroplasties and 7 knee arthroplasties among centenarians in this database.

45 There are large variations in the use of knee arthroplasty among Medicare enrollees according to

46 mbolism were 0.27% (95% CI, 0.16%-0.38%) for knee arthroplasty and 0.14% (95% CI, 0.07%-0.21%) for hi

47 tic DVT were 0.63% (95% CI, 0.47%-0.78%) for knee arthroplasty and 0.26% (95% CI, 0.14%-0.37%) for hi

48 overall 30-day mortality was 0.6% following knee arthroplasty and 0.7% following hip arthroplasty, w

49 udy population, 2009 of whom underwent total knee arthroplasty and 2298 of whom underwent total hip a

50 from 28 patients with proved infected total knee arthroplasty and 28 patients with noninfected arthr

51 abase, data on 12,108 patients who underwent knee arthroplasty and 6,703 patients who underwent hip a

52 Synovium samples were collected during total knee arthroplasty and assigned to histopathology or cycl

53 ed patients in the United States with hip or knee arthroplasty and continuous insurance enrollment 3

54 osteophytic fibrocartilage were obtained at knee arthroplasty and cultured ex vivo with or without I

55 ular injection (MCPI) in patients undergoing knee arthroplasty and evaluate their safety.

56 Among older patients undergoing hip or knee arthroplasty and receiving warfarin prophylaxis, an

57 Pain management after total knee arthroplasty and total hip arthroplasty is pivotal,

58 Among patients undergoing elective hip or knee arthroplasty and treated with perioperative warfari

59 lder initiating warfarin for elective hip or knee arthroplasty and was conducted at 6 US medical cent

60 pass grafting, total hip arthroplasty, total knee arthroplasty, and heart valve replacement) were ana

61 AMP from 4472 randomly selected cardiac, hip/knee arthroplasty, and hysterectomy cases.

62 eurysm repair, total hip arthroplasty, total knee arthroplasty, and lung resection were identified.

63 pic cholecystectomy, inguinal hernia repair, knee arthroplasty, and spinal fusion).

64 ectomy, prostatectomy, lung resection, total knee arthroplasty, and total hip arthroplasty-between 20

65 arthroplasty, 18 316 (62.6%) underwent total knee arthroplasty; and median (IQR) age was 59 (55-63) y

66 tes of infection-related complications after knee arthroplasty are higher in Hispanic patients than i

67 In the US population, hip and knee arthroplasty are very rarely performed among centen

68 a prevent venous thromboembolism after total knee arthroplasty as well as, or better than, low molecu

69 lder initiating warfarin for elective hip or knee arthroplasty at 6 US medical centers.

70 patients undergoing aseptic revision hip and knee arthroplasty at five institutional databases from 2

71 cteristics of patients undergoing outpatient knee arthroplasty at hospital-owned surgery centers (HOS

72 rvical spine fusion for myelopathy, or total knee arthroplasty at hospitals in California were abstra

73 ed the effects of bicruciate-retaining total knee arthroplasty (BCR-TKA) on knee kinematics and cruci

74 lobectomy, total hip arthroplasty, and total knee arthroplasty between 2015 and 2022.

75 gnosis of invasive SSI was delayed following knee arthroplasty compared with hip arthroplasty.

76 of tibial and femoral components after total knee arthroplasty compared with single-energy CT or radi

77 on-infection-related complications following knee arthroplasty, compared with white patients.

78 for patients at risk of poor outcomes after knee arthroplasty: CORKA RCT.

79 e Classification System codes using revision knee arthroplasty data from 2008 to 2018, provided by th

80 complex S. aureus SSIs decreased for hip or knee arthroplasties (difference per 10,000 operations, -

81 cohort study of patients undergoing primary knee arthroplasty (either total or unicompartmental arth

82 total hip arthroplasty (5% longer) and total knee arthroplasty (equal duration).

83 Sixty synovial fluid samples from knee arthroplasty failure archived at -80 degrees C were

84 analysis to patients undergoing total hip or knee arthroplasty for a diagnosis of osteoarthritis only

85 Among patients undergoing hip or knee arthroplasty for osteoarthritis, aspirin compared w

86 aluating the use of ACSS in a 2-stage hip or knee arthroplasty for treatment of PJI (1988 through Aug

87 ients undergoing elective total hip or total knee arthroplasty from 2004 to 2017.

88 im indicating an elective total hip or total knee arthroplasty from January 1, 2004, to December 31,

89 tients undergoing conversion or revision hip/knee arthroplasty from July 2020 to November 2022.

90 In 2018, Medicare removed total knee arthroplasty from the list of inpatient-only proced

91 ion and osseointegration that mimics partial knee arthroplasty, genetic ablation of LEPR(+) cells pre

92 ated hyperintense synovitis at MR imaging of knee arthroplasty had a high sensitivity and specificity

93 tients (n = 35) who underwent elective total knee arthroplasty had venous blood samples collected pre

94 52-1.03], P = 0.07), and not significant for knee arthroplasty (HR 0.87 [95% CI 0.71-1.07], P = 0.19)

95 found no association between statin use and knee arthroplasty (HR, 1.04; 95% CI, .99-1.09).

96 endarterectomy (CEA), spinal fusion, hip or knee arthroplasty, hysterectomy, or cesarean delivery be

97 r, mastectomy, lumpectomy, hip arthroplasty, knee arthroplasty, hysterectomy, spinal fusion, and vert

98 For example, the incidence rate of total knee arthroplasty in 2012 for White males was 184.8 per

99 For example, the incidence rate of total knee arthroplasty in 2017 for White males was 220.5 per

100 the number of patients undergoing outpatient knee arthroplasty in 2018 corresponded to FASCs treating

101 The increasing number of revision knee arthroplasty in Germany, especially in younger pati

102 ecent decrease in the rates of primary total knee arthroplasty in patients with RA.

103 aving elective, outpatient partial and total knee arthroplasty in the Florida and Wisconsin State Amb

104 Outpatient knee arthroplasties increased from 1910 in 2017 to 3747

105 atient rehabilitation after elective hip and knee arthroplasty is often necessary for patients who ca

106 oprophylaxis agent after total hip and total knee arthroplasty is uncertain and consensus is lacking.

107 ximelagatran started the morning after total knee arthroplasty is well tolerated and at least as effe

108 ween patient expectations and outcomes after knee arthroplasty (KA) in an Asian population in Singapo

109 ne synovial tissues were procured from total knee arthroplasty of hemophilia patients (males, 40.8 +/

110 ulable state (OR, 2.64 [95% CI, 1.32-5.28]), knee arthroplasty (OR, 1.65 [95% CI, 1.29-2.10]), and ma

111 ficiency and safety of steroids with MCPI in knee arthroplasty patients during the early postoperativ

112 Among patients undergoing knee arthroplasty, postoperative osocimab 0.6 mg/kg, 1.2

113 lization for cervical spine surgery or total knee arthroplasty (primary and revision), although in 19

114 ents (aged >=18 years) undergoing any hip or knee arthroplasty procedure at participating sites durin

115 g questions: (1) How did numbers of revision knee arthroplasty procedures develop in Germany over the

116 Patients (aged >=18 years) undergoing hip or knee arthroplasty procedures were enrolled at each hospi

117 ays after hip arthroplasty and 14 days after knee arthroplasty procedures.

118 edures, including cardiac bypass and hip and knee arthroplasty procedures.

119 y a monitored home-based program after total knee arthroplasty provided greater improvements than a m

120 Hence, 12.6% of knee arthroplasties required a revision in 2018.

121 isk of infection-related complications after knee arthroplasty (RR 1.64, 95% CI 1.08-2.49) relative t

122 ned from tissue donors and OA cartilage from knee arthroplasty specimens.

123 Among patients undergoing knee arthroplasty, surgical-site infections occurred in

124 Among adults undergoing uncomplicated total knee arthroplasty, the use of inpatient rehabilitation c

125 ing aspirin with enoxaparin following hip or knee arthroplasty, there was no significant between-grou

126 Despite the frequency of total knee arthroplasty (TKA) and clinical implications of pro

127 The adverse outcomes after total knee arthroplasty (TKA) associated with preoperative pre

128 us studies on rehabilitation following total knee arthroplasty (TKA) demonstrated limited efficacy in

129 A subset of patients undergoing total knee arthroplasty (TKA) for knee osteoarthritis develop

130 The AG, which can be sampled during total knee arthroplasty (TKA) for kOA, can provide information

131 ople with severe obesity who undergo a total knee arthroplasty (TKA) for osteoarthritis (OA) are at h

132 otal hip arthroplasty (THA) and 92 had total knee arthroplasty (TKA) infections.

133 Arthrofibrosis following total knee arthroplasty (TKA) is a debilitating condition typi

134 hatic drainage (MLD) following primary total knee arthroplasty (TKA) is effective in reducing pain an

135 Total knee arthroplasty (TKA) is one of the most common and co

136 Total knee arthroplasty (TKA) is one of the most successful or

137 arch provides convincing evidence that total knee arthroplasty (TKA) is safe and improves joint-speci

138 Although frequently observed following total knee arthroplasty (TKA) no therapeutic options exist.

139 Background Because loosening of total knee arthroplasty (TKA) occurs due to poor osseous integ

140 963 primary and revision total hip (THA) and knee arthroplasty (TKA) patients operated between 2009 a

141 Total knee arthroplasty (TKA) periprosthetic joint infection (

142 s a major failure mechanism leading to total knee arthroplasty (TKA) revision.

143 dictions for functional recovery after Total Knee Arthroplasty (TKA) surgery, using a novel neighbors

144 While total knee arthroplasty (TKA) typically results in the reducti

145 ed for total hip arthroplasty (THA) or total knee arthroplasty (TKA) were randomized to a 6-week exer

146 Total knee arthroplasty (TKA) with hardware around the knee is

147 h knee osteoarthritis (KOA) undergoing total knee arthroplasty (TKA), a procedure which is curative f

148 considered when choosing where to get total knee arthroplasty (TKA), but currently available quality

149 In total knee arthroplasty (TKA), correcting or maintaining coron

150 s available to predict the outcomes of total knee arthroplasty (TKA), the effect of these predictive

151 ing synovial patterns in patients with total knee arthroplasty (TKA), whether diagnostic accuracy dif

152 of patients develop chronic pain after total knee arthroplasty (TKA), yet there is a scarcity of effe

153 ience improved physical function after total knee arthroplasty (TKA).

154 ly been used for local infiltration in total knee arthroplasty (TKA).

155 lowing total hip arthroplasty (THA) or total knee arthroplasty (TKA).

156 man model of surgery-induced fibrosis, total knee arthroplasty (TKA).

157 rimary total hip arthroplasty (THA) or total knee arthroplasty (TKA).

158 r U.S. adults are projected to undergo total knee arthroplasty (TKA).

159 itudinal trends in the epidemiology of total knee arthroplasty (TKA).

160 an follow-up period of 14 months after total knee arthroplasty (TKA).

161 tis (OA) of the knee delays or hastens total knee arthroplasty (TKA); opposite findings have been rep

162 ee osteoarthritis scheduled to undergo total knee arthroplasty (TKA; n = 24).

163 hip arthroplasties (THAs) and primary total knee arthroplasties (TKAs) comprising all primary total

164 ations from assessment (range: 42% for total knee arthroplasty to 96% for laparoscopic cholecystectom

165 e randomly assigned 1242 patients undergoing knee arthroplasty to receive one of seven postoperative

166 igned 412 patients who were undergoing total knee arthroplasty to receive one of three regimens of ab

167 undergoing elective primary unilateral total knee arthroplasty to receive one of two doses of FXI-ASO

168 thromboembolism (VTE) after total or partial knee arthroplasty (TPKA) and after total or partial hip

169 The Total or Partial Knee Arthroplasty Trial (TOPKAT) therefore aims to asses

170 cruciate ligament force in unicompartmental knee arthroplasty (UKA) and determined whether kinematic

171 al knee OA and after medial unicompartmental knee arthroplasty (UKA) remain to be elucidated.

172 asty vs 42 days (IQR, 21-114 days) following knee arthroplasty (unadjusted hazard ratio [HR], 1.60; 9

173 of patients who underwent total hip or total knee arthroplasty, underlying patient risk factors, but

174 y or proctectomy, hysterectomy, total hip or knee arthroplasty, ventral hernia repair, and lower extr

175 undergoing elective primary unilateral total knee arthroplasty was an effective method for its preven

176 The influx of patients undergoing outpatient knee arthroplasty was associated with an amplification o

177 e intravenous dose of abelacimab after total knee arthroplasty was effective for the prevention of ve

178 n with oral milvexian in patients undergoing knee arthroplasty was effective for the prevention of ve

179 At the national level, the annual rate of knee arthroplasty was higher for non-Hispanic white wome

180 Total knee arthroplasty was identified by linking the randomiz

181 he risk of hospitalization for primary total knee arthroplasty was significantly lower in 1998-2001 t

182 A total of 430,726 knee arthroplasties were performed during the three-year

183 In 2018, a total number 23,812 revision knee arthroplasties were performed in Germany, yielding

184 , electrotherapy and acupuncture after total knee arthroplasty were associated with reduced and delay

185 ed and infection-related complications after knee arthroplasty were higher among black patients compa

186 65 years) undergoing elective primary hip or knee arthroplasty were postoperatively assessed for deli

187 Adult patients undergoing unilateral knee arthroplasty were randomized from October 2017 thro

188 Patients with OA receiving total hip or knee arthroplasty were recruited and completed two sets

189 Candidates for total hip or total knee arthroplasty were reviewed in a multicenter cohort

190 with osteoarthritis undergoing primary total knee arthroplasty were screened for eligibility.

191 Total knee arthroplasty with or without a limb tourniquet.